Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas

Human Pathology

Volumn 39, Issue 5, 2008, Pages 758-766

  Gejman, Roger ^a   Swearingen, Brooke ^a   Hedley Whyte, E Tessa ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Immunohistochemistry; Pituitary adenoma; Proliferation indices

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; SEX DIFFERENCE; TUMOR BIOPSY; TUMOR RECURRENCE; TUMOR VOLUME;

ADENOMA; ADOLESCENT; ADULT; AGED; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PITUITARY NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 42649093541     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.10.004     Document Type: Article

References (36)

1. Ezzat S., Asa S.L., Couldwell W.T., et al. The prevalence of pituitary adenomas: a systematic review. Cancer 101 (2004) 613-619
2. Hsu D.W., Hakim F., Biller B.M., et al. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 78 (1993) 753-761
3. Thapar K., Yamada Y., Scheithauer B., Kovacs K., Yamada S., and Stefaneanu L. Assessment of mitotic activity in pituitary adenomas and carcinomas. Endocr Pathol 7 (1996) 215-221
4. Scheithauer B.W., Kovacs K.T., Laws Jr. E.R., and Randall R.V. Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65 (1986) 733-744
5. Sautner D., and Saeger W. Invasiveness of pituitary adenomas. Pathol Res Pract 187 (1991) 632-636
6. Schreiber S., Saeger W., and Ludecke D.K. Proliferation markers in different types of clinically non-secreting pituitary adenomas. Pituitary 1 (1999) 213-220
7. Louis D.N., Edgerton S., Thor A.D., and Hedley-Whyte E.T. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study. Acta Neuropathol (Berl) 81 (1991) 675-679
8. Heegaard S., Sommer H.M., Broholm H., and Broendstrup O. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis. Cancer 76 (1995) 1809-1813
9. Scholzen T., and Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 182 (2000) 311-322
10. Key G., Becker M.H., Baron B., et al. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 68 (1993) 629-636
11. DeLellis R. Pathology and Genetics of Tumours of Endocrine Organs, WHO Classification of Tumours (2004), IARC Press, Lyon
12. Mizoue T., Kawamoto H., Arita K., Kurisu K., Tominaga A., and Uozumi T. MIB1 immunopositivity is associated with rapid regrowth of pituitary adenomas. Acta Neurochir (Wien) 139 (1997) 426-431 discussion 431-2
13. Losa M., Franzin A., Mangili F., et al. Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results. Neurosurgery 47 (2000) 1313-1318 discussion 1318-9
14. Tanaka Y., Hongo K., Tada T., Sakai K., Kakizawa Y., and Kobayashi S. Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index. J Neurosurg 98 (2003) 359-365
15. Honegger J., Prettin C., Feuerhake F., Petrick M., Schulte-Monting J., and Reincke M. Expression of Ki-67 antigen in nonfunctioning pituitary adenomas: correlation with growth velocity and invasiveness. J Neurosurg 99 (2003) 674-679
16. Hentschel S.J., McCutcheon E., Moore W., and Durity F.A. P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas. Can J Neurol Sci 30 (2003) 215-219
17. Thapar K., Scheithauer B.W., Kovacs K., Pernicone P.J., and Laws Jr. E.R. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 38 (1996) 765-770 discussion 770-1
18. Miyagami M., and Nakamura S. Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas. No To Shinkei 50 (1998) 27-32
19. Eng J. Receiver operating characteristic analysis: a primer. Acad Radiol 12 (2005) 909-916
20. Ekramullah S.M., Saitoh Y., Arita N., Ohnishi T., and Hayakawa T. The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas. Acta Neurochir (Wien) 138 (1996) 1449-1455
21. Landolt A.M., Shibata T., and Kleihues P. Growth rate of human pituitary adenomas. J Neurosurg 67 (1987) 803-806
22. Knosp E., Kitz K., and Perneczky A. Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Neurosurgery 25 (1989) 927-930
23. Delgrange E., Trouillas J., Maiter D., Donckier J., and Tourniaire J. Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab 82 (1997) 2102-2107
24. Shibuya M., Saito F., Miwa T., Davis R.L., Wilson C.B., and Hoshino T. Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. Acta Neuropathol (Berl) 84 (1992) 178-183
25. Abe T., Sanno N., Osamura Y.R., and Matsumoto K. Proliferative potential in pituitary adenomas: measurement by monoclonal antibody MIB-1. Acta Neurochir (Wien) 139 (1997) 613-618
26. Thapar K., Kovacs K., Scheithauer B.W., et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38 (1996) 99-106 discussion 106-7
27. Jaffrain-Rea M.L., Di Stefano D., Minniti G., et al. A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas. Endocr Relat Cancer 9 (2002) 103-113
28. Turner H.E., and Wass J.A. Are markers of proliferation valuable in the histological assessment of pituitary tumours?. Pituitary 1 (1999) 147-151
29. Zuber P., Hamou M.F., and de Tribolet N. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67. Neurosurgery 22 (1988) 364-368
30. Paek K.I., Kim S.H., Song S.H., et al. Clinical significance of Ki-67 labeling index in pituitary macroadenoma. J Korean Med Sci 20 (2005) 489-494
31. Mastronardi L., Guiducci A., and Puzzilli F. Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas. BMC Cancer 1 (2001) 12
32. Mastronardi L., Guiducci A., Spera C., Puzzilli F., Liberati F., and Maira G. Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody. J Clin Pathol 52 (1999) 107-111
33. Ferreira J.E., de Mello P.A., de Magalhaes A.V., et al. Non-functioning pituitary adenomas: clinical features and immunohistochemistry. Arq Neuropsiquiatr 63 (2005) 1070-1078
34. Botelho C.H., Magalhaes A.V., Mello P.A., Schmitt F.C., and Casulari L.A. Expression of p53, Ki-67 and c-erb B2 in growth hormone- and/or prolactin-secreting pituitary adenomas. Arq Neuropsiquiatr 64 (2006) 60-66
35. Amin M.R., Kurosaki M., Watanabe T., Tanaka S., and Hori T. A comparative study of MIB-1 staining indices of gliomas measured by NIH Image analysis program and conventional manual cell counting method. Neurol Res 22 (2000) 495-500
36. Hasegawa T., Yamamoto S., and Matsuno Y. Quantitative immunohistochemical evaluation of MIB-1 labeling index in adult soft-tissue sarcomas by computer-assisted image analysis. Pathol Int 52 (2002) 433-437